PODD: Insulet Corporation Forward P/E Multiple
Insulet Corporation (PODD) is protected by patents and strict FDA oversight within a niche medtech segment. Revenues are growing driven by a unique subscription model for consumables. The company's forward 12-month P/E ratio visualizes this resilience, where 18.80 describes the current status of the metric. High-margin demand for Omnipod tubeless systems promises to turn the product into a global therapy standard.
Insulet Inc. (PODD) - metric breakdowns and financial figures
- stock value and consensus price forecast:
- market capitalization information:
- book capitalization information:
- debt and liquidity details:
Total Debt to Capital Insulet Corporation|PODD - Long-Term Debt to Capital Ratio|Short-Term Debt to Equity Ratio Insulet Corporation|PODD - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Insulet Corp|PODD - Company Long-Term Liabilities|Company Short-Term Debts Insulet|Quick Ratio insulet.com
- financial results and valuation multiples details:
PODD - Company Profit|Projected Future Earnings Insulet Corporation|PODD - Business Payback Period|Forward P/E Multiple OmniPod|PODD - Price/Earnings to Growth Multiple|EV/EBITDA Multiple Insulet Corp|PODD - Operating profit EBITDA|Earnings per share for the last twelve months Insulet|PODD - Earnings per share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months insulet.com|PODD - Earnings per share increase in current year|Earnings growth forecast for next year Insulet Corporation
- sales and revenue indicators:
Fundamental valuation:PODD Insulet
Insulet Corporation (PODD) dominates the wireless insulin pump segment driven by steady demand for consumables. The company's forward P/E ratio trend compares current market capitalization with expected earnings for the coming year. This calculation reveals the extent to which investors are paying a premium for future growth. High repeat purchase rates for pods confirm the resilience of the cash flow. This chart's current trend indicates a fair valuation of the business's fundamental value.
Competitors of Insulet Corporation
Future Price to Earnings Boston Scientific Corporation (BSX)|Future Price to Earnings EW (Edwards)|Forward P/E Multiple RMD (ResMed Corp)|Market Cap to Projected Earnings Zimmer Biomet (ZBH)|COO: Projected Price to Earnings|Price to Expected Earnings Ratio ALGN|GMED: Forward P/E Multiple|Projected Price to Earnings Ratio TransMedics Organ Care System (TMDX)|ATEC (ATEC Spine) - Forward P/E Multiple|Price to Future Earnings Ratio AORT (Artivion Corp)|Projected Price to Earnings ENOV (Enovis Corporation)|IART (integralife.com) - Future Price to Earnings Multiple|Future Price to Earnings Establishment Labs Holdings Inc. ESTA|BBNX - Projected Price to Earnings|Iradimed - Forward P/E Multiple|Projected Price to Earnings Ratio Embecta Health|TNDM: Forward P/E Multiple|Price to Future Earnings Ratio AXGN|SIBN (SI-BONE) - Forward P/E Multiple|Orthofix Medical (OFIX) - Market Cap to Projected Earnings|Forward P/E Multiple BVS|Projected Price to Earnings orthopediatrics.com KIDS|Forward P/E Multiple TMCI (Treace Medical Concepts)|Forward P/E Multiple blade.com SRTA|CARL - Future Price to Earnings|RXST: Future Price to Earnings|CLPT (clearpointneuro.com) - Projected Price to Earnings|Stereotaxis Corporation - Future Price to Earnings Multiple|STIM (Neuronetics, Inc.) - Forward P/E Multiple|Projected Price to Earnings Ratio sightsciences.com SGHT|Future Price to Earnings Orchestra BioMed, Inc. (OBIO)|anikatherapeutics.com (ANIK) - Forward Price to Earnings Multiple|InspireMD Corp - Projected Price to Earnings|Forward P/E Multiple Jin Medical International Ltd. ZJYL|Vivani - Forward P/E Multiple|Market Cap to Projected Earnings Xtant Medical Holdings XTNT|NeuroOne Medical Technologies Corporation (NMTC) - Future Price to Earnings|Price to Expected Earnings Ratio MODD (Modular Medical, Inc.)|Future Price to Earnings Myomo, Inc|Projected Price to Earnings Envoy Medical Inc (COCH)|Forward P/E Multiple VVOS|NVNO - Projected Price to Earnings Ratio|Future Price to Earnings Sintx Technologies, Inc. SINT|TNON: Price to Future Earnings Ratio|LFWD: Projected Price to Earnings|Autonomix Medical, Inc. - Market Cap to Future Earnings Ratio|IVF: Forward P/E Multiple|BBLG - Market Cap to Projected Earnings|Future Price to Earnings Axonics|Price to Future Earnings Ratio BIOL (BIOLASE Inc.)|Future Price to Earnings Dynatronics Corporation (DYNT)|Market Cap to Projected Earnings paragon28.com|INVO Bioscience - Projected Price to Earnings
